HOWL Insider Transactions — Page 3
587 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 201–300; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2025-11-28 | Sale | 20,277.0 | $0.99 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2025-11-28 | Sale | 20,277.0 | $0.99 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2025-11-28 | Sale | 20,277.0 | $0.99 |
| EVNIN LUKE | Director | 2025-11-28 | Sale | 13,014.0 | $0.99 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-11-26 | Sale | 60,733.0 | $0.98 |
| MPM BioVentures 2014 (B), L.P. | TenPercentOwner | 2025-11-26 | Sale | 60,733.0 | $0.98 |
| MPM Asset Management Investors BV2014 LLC | TenPercentOwner | 2025-11-26 | Sale | 60,733.0 | $0.98 |
| MPM BioVentures 2014 LLC | TenPercentOwner | 2025-11-26 | Sale | 60,733.0 | $0.98 |
| MPM BioVentures 2014 GP LLC | TenPercentOwner | 2025-11-26 | Sale | 60,733.0 | $0.98 |
| GADICKE ANSBERT | TenPercentOwner | 2025-11-26 | Sale | 60,733.0 | $0.98 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2025-11-26 | Sale | 60,733.0 | $0.98 |
| MPM BioImpact LLC | TenPercentOwner | 2025-11-26 | Sale | 60,733.0 | $0.98 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2025-11-26 | Sale | 60,733.0 | $0.98 |
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2025-11-26 | Sale | 60,733.0 | $0.98 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2025-11-26 | Sale | 60,733.0 | $0.98 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2025-11-26 | Sale | 60,733.0 | $0.98 |
| EVNIN LUKE | Director | 2025-11-26 | Sale | 38,978.0 | $0.98 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-11-25 | Sale | 42,533.0 | $0.92 |
| MPM BioVentures 2014 (B), L.P. | TenPercentOwner | 2025-11-25 | Sale | 42,533.0 | $0.92 |
| MPM Asset Management Investors BV2014 LLC | TenPercentOwner | 2025-11-25 | Sale | 42,533.0 | $0.92 |
| MPM BioVentures 2014 LLC | TenPercentOwner | 2025-11-25 | Sale | 42,533.0 | $0.92 |
| MPM BioVentures 2014 GP LLC | TenPercentOwner | 2025-11-25 | Sale | 42,533.0 | $0.92 |
| GADICKE ANSBERT | TenPercentOwner | 2025-11-25 | Sale | 42,533.0 | $0.92 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2025-11-25 | Sale | 42,533.0 | $0.92 |
| MPM BioImpact LLC | TenPercentOwner | 2025-11-25 | Sale | 42,533.0 | $0.92 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2025-11-25 | Sale | 42,533.0 | $0.92 |
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2025-11-25 | Sale | 42,533.0 | $0.92 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2025-11-25 | Sale | 42,533.0 | $0.92 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2025-11-25 | Sale | 42,533.0 | $0.92 |
| EVNIN LUKE | Director | 2025-11-25 | Sale | 27,297.0 | $0.92 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-11-24 | Sale | 88,802.0 | $0.98 |
| MPM BioVentures 2014 (B), L.P. | TenPercentOwner | 2025-11-24 | Sale | 88,802.0 | $0.98 |
| MPM Asset Management Investors BV2014 LLC | TenPercentOwner | 2025-11-24 | Sale | 88,802.0 | $0.98 |
| MPM BioVentures 2014 LLC | TenPercentOwner | 2025-11-24 | Sale | 88,802.0 | $0.98 |
| MPM BioVentures 2014 GP LLC | TenPercentOwner | 2025-11-24 | Sale | 88,802.0 | $0.98 |
| GADICKE ANSBERT | TenPercentOwner | 2025-11-24 | Sale | 88,802.0 | $0.98 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2025-11-24 | Sale | 88,802.0 | $0.98 |
| MPM BioImpact LLC | TenPercentOwner | 2025-11-24 | Sale | 88,802.0 | $0.98 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2025-11-24 | Sale | 88,802.0 | $0.98 |
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2025-11-24 | Sale | 88,802.0 | $0.98 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2025-11-24 | Sale | 88,802.0 | $0.98 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2025-11-24 | Sale | 88,802.0 | $0.98 |
| EVNIN LUKE | Director | 2025-11-24 | Sale | 56,992.0 | $0.98 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-11-21 | Sale | 64,331.0 | $0.83 |
| MPM BioVentures 2014 (B), L.P. | TenPercentOwner | 2025-11-21 | Sale | 64,331.0 | $0.83 |
| MPM Asset Management Investors BV2014 LLC | TenPercentOwner | 2025-11-21 | Sale | 64,331.0 | $0.83 |
| MPM BioVentures 2014 LLC | TenPercentOwner | 2025-11-21 | Sale | 64,331.0 | $0.83 |
| MPM BioVentures 2014 GP LLC | TenPercentOwner | 2025-11-21 | Sale | 64,331.0 | $0.83 |
| GADICKE ANSBERT | TenPercentOwner | 2025-11-21 | Sale | 64,331.0 | $0.83 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2025-11-21 | Sale | 64,331.0 | $0.83 |
| MPM BioImpact LLC | TenPercentOwner | 2025-11-21 | Sale | 64,331.0 | $0.83 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2025-11-21 | Sale | 64,331.0 | $0.83 |
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2025-11-21 | Sale | 64,331.0 | $0.83 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2025-11-21 | Sale | 64,331.0 | $0.83 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2025-11-21 | Sale | 64,331.0 | $0.83 |
| EVNIN LUKE | Director | 2025-11-21 | Sale | 41,287.0 | $0.83 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-11-20 | Sale | 41,152.0 | $0.89 |
| MPM BioVentures 2014 (B), L.P. | TenPercentOwner | 2025-11-20 | Sale | 41,152.0 | $0.89 |
| MPM Asset Management Investors BV2014 LLC | TenPercentOwner | 2025-11-20 | Sale | 41,152.0 | $0.89 |
| MPM BioVentures 2014 LLC | TenPercentOwner | 2025-11-20 | Sale | 41,152.0 | $0.89 |
| MPM BioVentures 2014 GP LLC | TenPercentOwner | 2025-11-20 | Sale | 41,152.0 | $0.89 |
| GADICKE ANSBERT | TenPercentOwner | 2025-11-20 | Sale | 41,152.0 | $0.89 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2025-11-20 | Sale | 41,152.0 | $0.89 |
| MPM BioImpact LLC | TenPercentOwner | 2025-11-20 | Sale | 41,152.0 | $0.89 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2025-11-20 | Sale | 41,152.0 | $0.89 |
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2025-11-20 | Sale | 41,152.0 | $0.89 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2025-11-20 | Sale | 41,152.0 | $0.89 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2025-11-20 | Sale | 41,152.0 | $0.89 |
| EVNIN LUKE | Director | 2025-11-20 | Sale | 26,411.0 | $0.89 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-11-19 | Sale | 66,324.0 | $0.94 |
| MPM BioVentures 2014 (B), L.P. | TenPercentOwner | 2025-11-19 | Sale | 66,324.0 | $0.94 |
| MPM Asset Management Investors BV2014 LLC | TenPercentOwner | 2025-11-19 | Sale | 66,324.0 | $0.94 |
| MPM BioVentures 2014 LLC | TenPercentOwner | 2025-11-19 | Sale | 66,324.0 | $0.94 |
| MPM BioVentures 2014 GP LLC | TenPercentOwner | 2025-11-19 | Sale | 66,324.0 | $0.94 |
| GADICKE ANSBERT | TenPercentOwner | 2025-11-19 | Sale | 66,324.0 | $0.94 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2025-11-19 | Sale | 66,324.0 | $0.94 |
| MPM BioImpact LLC | TenPercentOwner | 2025-11-19 | Sale | 66,324.0 | $0.94 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2025-11-19 | Sale | 66,324.0 | $0.94 |
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2025-11-19 | Sale | 66,324.0 | $0.94 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2025-11-19 | Sale | 66,324.0 | $0.94 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2025-11-19 | Sale | 66,324.0 | $0.94 |
| EVNIN LUKE | Director | 2025-11-19 | Sale | 42,566.0 | $0.94 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-11-18 | Sale | 52,627.0 | $0.93 |
| MPM BioVentures 2014 (B), L.P. | TenPercentOwner | 2025-11-18 | Sale | 52,627.0 | $0.93 |
| MPM Asset Management Investors BV2014 LLC | TenPercentOwner | 2025-11-18 | Sale | 52,627.0 | $0.93 |
| MPM BioVentures 2014 LLC | TenPercentOwner | 2025-11-18 | Sale | 52,627.0 | $0.93 |
| MPM BioVentures 2014 GP LLC | TenPercentOwner | 2025-11-18 | Sale | 52,627.0 | $0.93 |
| GADICKE ANSBERT | TenPercentOwner | 2025-11-18 | Sale | 52,627.0 | $0.93 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2025-11-18 | Sale | 52,627.0 | $0.93 |
| MPM BioImpact LLC | TenPercentOwner | 2025-11-18 | Sale | 52,627.0 | $0.93 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2025-11-18 | Sale | 52,627.0 | $0.93 |
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2025-11-18 | Sale | 52,627.0 | $0.93 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2025-11-18 | Sale | 52,627.0 | $0.93 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2025-11-18 | Sale | 52,627.0 | $0.93 |
| EVNIN LUKE | Director | 2025-11-18 | Sale | 33,776.0 | $0.93 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-11-17 | Sale | 57,061.0 | $0.95 |
| MPM BioVentures 2014 (B), L.P. | TenPercentOwner | 2025-11-17 | Sale | 57,061.0 | $0.95 |
| MPM Asset Management Investors BV2014 LLC | TenPercentOwner | 2025-11-17 | Sale | 57,061.0 | $0.95 |
| MPM BioVentures 2014 LLC | TenPercentOwner | 2025-11-17 | Sale | 57,061.0 | $0.95 |
| MPM BioVentures 2014 GP LLC | TenPercentOwner | 2025-11-17 | Sale | 57,061.0 | $0.95 |